Silver Creek Pharmaceuticals is scheduled to present at the 13th annual BIO Investor Forum on October 7th at 2 p.m. (PT) in San Francisco. Matt Onsum will present Silver Creek’s proprietary Smart Growth Factor technology and its application to treating heart disease. The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. More information on this event may be found here (link).